Company Search:
Advanced Search
Sponsored Links
Aska Pharmaceutical Company Limited Company Snapshot
Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aska Pharmaceutical Company Limited with three other companies in this sector in Japan: Iwaki & Co., Ltd. (2017 sales of 57.39 billion Japanese Yen [US$535.43 million] ), Katakura Industries Co Ltd (46.19 billion Japanese Yen [US$430.91 million] ), and Fuso Pharmaceutical Industries Ltd (46.78 billion Japanese Yen [US$436.48 million] of which 100% was Pharmaceutical Business).

Sales Analysis. Aska Pharmaceutical Company Limited reported sales of ¥48.53 billion (US$452.76 million) for the fiscal year ending March of 2017. This represents an increase of 12.3% versus 2016, when the company's sales were ¥43.22 billion. This was the third consecutive year of growth at Aska Pharmaceutical Company Limited. Sales of Pharmaceutical Products Business saw an increase of 13.2% in 2017, from ¥38.96 billion to ¥44.08 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aska Pharmaceutical Company Limited
  Stock Performance Chart for Aska Pharmaceutical Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1,693.00
(Figures in Japanese Yen)
1 Week -2.0%   13 Weeks -0.2%  
4 Weeks -17.0%   52 Weeks 7.3%  
Aska Pharmaceutical Company Limited Key Data:
  Ticker: 4514 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 48,527,000,000
(Year Ending Jan 2018).
Employees: 862
  Currency: Japanese Yen Market Cap: 47,727,139,524
  Fiscal Yr Ends: March Shares Outstanding: 28,190,868
  Share Type: Common Closely Held Shares: 7,600,050
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.